BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180321
DTEND;VALUE=DATE:20180323
DTSTAMP:20260515T083509
CREATED:20171019T103727Z
LAST-MODIFIED:20171019T103727Z
UID:3505-1521590400-1521763199@www.pharmajournalist.com
SUMMARY:Drug Discovery 
DESCRIPTION:SMi Group is proud to announce the return of Drug Discovery in 2018. The successful conference will return for its 2nd year on the 21st and 22nd March. \n \nThe pharmaceutical industry is constantly battling the same issue when trying to discover drugs; the process is timely\, expensive and usually unsuccessful. Pharma companies are trying to speed up the procedure to make it more accurate and minimise drug leads which are likely to fail further on in the drug development process. Consequently\, the event will focus on key developments in this very industry. \nSMi’s 2nd annual Drug Discovery conference provides an unprecedented opportunity to gain insight into the use of Artificial Intelligence in silico drug discovery\, CRISPR and PROTAC’s\, as well as discussing advancements in medicinal chemistry\, translational medicine and 3D structure based-discovery. \nWith huge interest from leaders in the field\, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Drug Discovery yet. This year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers: \n– Chairman – Darren Green\, Director of Computational Chemistry and Informatics\, GlaxoSmithKline plc\n– Chairman – Guido Hanauer\, CEO\, GHPC GmbH\n– Steve Rees\, Vice-President\, Screening Sciences and Sample Management at AstraZeneca\, Astra Zeneca Plc\n– Claus Bendtsen\, Executive Director/Sr Leader Data Science\, AstraZeneca\n– Ralph Minter\, Director\, Fellow\, Antibody Discovery and Protein Engineering\, MedImmune\n– Stevan Djuric\, Vice President\, AbbVie\n– John Harling\, Director of Chemistry for the Protein Degradation DPU\, GlaxoSmithKline plc\n– Ursula Egner\, Director Process Simulation and Design Collaboration\, Bayer HealthCare \nEarly bird discounts! \n\nRegister by the 30th November to save £400\n15th December to save £200\n31st January to save £100
URL:https://www.pharmajournalist.com/event/drug-discovery/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:nboumediene@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180321
DTEND;VALUE=DATE:20180323
DTSTAMP:20260515T083509
CREATED:20171031T052535Z
LAST-MODIFIED:20171031T052710Z
UID:3711-1521590400-1521763199@www.pharmajournalist.com
SUMMARY:15th annual Controlled Release Delivery
DESCRIPTION:Building on the success of previous events\, SMi’s Controlled Release Delivery conference returns for its 15th year in London on 21-22 March 2018. \nAs physicians and scientists continue to find strategies to assist in simplifying treatment schedules for patients\, a pharma focus continues to move towards innovative controlled release technologies to improve drug transport to target. \nMoreover\, with the global oral controlled release drug delivery technology market expected to flourish in the next few years\, now is the time to get ahead of the game by exploring and understanding innovations in oral-lipid based and abuse deterrent formulations\, nanoparticles and nanotechnologies\, taste-masking and controlled release approaches\, 3D printed dosage forms and functional film coats. \nFeaturing presentations to analyse and evaluate latest advancements in drug delivery\, this year’s event highlights include: \n\nFormulation of Controlled Release Delivery Technologies and improving the design of new controlled release delivery systems\nInnovative additions to Oral Controlled Release Delivery Technologies\, to improve the pharmacokinetic-pharmacodynamic properties of the drug\nLatest regulation guidance and their implications for the pharmaceutical industry\nClinical developments and lessons learnt during clinical trials\, through case studies with top pharmaceutical companies\n\nFeatured speakers include senior decision makers and innovators from University of Strathclyde\, GSK\, Ipsen\, PLIVA\, SiTech Pharmabio\, Grunenthal\, Colorcon\, Bial\, Peptigel Design\, University of Central Lancashire and more! \nVisit www.controlledreleasedelivery.com/pharmajournalist to view the full list of speakers and their presentations. \nEARLY BIRD : Book by 30 November to save £400. Book by 15 December to save £200. Book by 31st January to save £100.
URL:https://www.pharmajournalist.com/event/15th-annual-controlled-release-delivery/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:hdegracia@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180321
DTEND;VALUE=DATE:20180324
DTSTAMP:20260515T083509
CREATED:20171205T022232Z
LAST-MODIFIED:20180103T070336Z
UID:4992-1521590400-1521849599@www.pharmajournalist.com
SUMMARY:ePharma
DESCRIPTION:Join more than 500 digital pharma marketers\, technologists\, and digital agencies at ePharma 2018 to discuss the ongoing digital evolution of marketing practices in pharma and biotech and the continual digitization of the patient and HCP journeys. \nePharma is a long-standing platform known to spark insightful conversations and inspire through instructional case studies\, out-of-industry perspectives\, and leading-edge technology\, providing attendees with strategies and tactics to grow as leaders\, embrace disruption\, and seize innovation. \nTo learn more about this event\, and to register online\, visit www.epharmasummit.com
URL:https://www.pharmajournalist.com/event/epharma/
LOCATION:New York Marriott Marquis
ORGANIZER;CN="Knect365%2C a division of Informa":MAILTO:frances.pratt@knect365.com
END:VEVENT
END:VCALENDAR